Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Helmut Maecke

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Tissue Distribution

Disorders

Living Beings

Rats
Mice

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Forrer Flavio; Chen Jianhua; Fani Melpomeni; Powell Pia; Lohri Andreas; Müller-Brand Jan; Moldenhauer Gerhard; Maecke Helmut R
In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study.
Mansi Rosalba; Wang Xuejuan; Forrer Flavio; Kneifel Stefan; Tamma Maria-Luisa; Waser Beatrice; Cescato Renzo; Reubi Jean Claude; Maecke Helmut R
Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides.
Waser Bea; Tamma Maria-Luisa; Cescato Renzo; Maecke Helmut R; Reubi Jean Claude
Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Helmut Maecke (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Forrer Flavio; Chen Jianhua; Fani Melpomeni; Powell Pia; Lohri Andreas; Müller-Brand Jan; Moldenhauer Gerhard; Maecke Helmut R
In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study.
European journal of nuclear medicine and molecular imaging 2009;36(9):1443-52.
2009: Mansi Rosalba; Wang Xuejuan; Forrer Flavio; Kneifel Stefan; Tamma Maria-Luisa; Waser Beatrice; Cescato Renzo; Reubi Jean Claude; Maecke Helmut R
Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(16):5240-9.
2009: Waser Bea; Tamma Maria-Luisa; Cescato Renzo; Maecke Helmut R; Reubi Jean Claude
Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(6):936-41.
2009: Iten Fabienne; Muller Beat; Schindler Christian; Rasch Helmut; Rochlitz Christoph; Oertli Daniel; Maecke Helmut R; Muller-Brand Jan; Walter Martin A
[(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial.
Cancer 2009;115(10):2052-62.
2008: Reubi Jean Claude; Maecke Helmut R
Peptide-based probes for cancer imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(11):1735-8.
2008: Good Stephan; Walter Martin A; Waser Beatrice; Wang Xuejuan; Müller-Brand Jan; Béhé Martin P; Reubi Jean-Claude; Maecke Helmut R
Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours.
European journal of nuclear medicine and molecular imaging 2008;35(10):1868-77.
2008: Abiraj Keelara; Jaccard Hugues; Kretzschmar Martin; Helm Lothar; Maecke Helmut R
Novel DOTA-based prochelator for divalent peptide vectorization: synthesis of dimeric bombesin analogues for multimodality tumor imaging and therapy.
Chemical communications (Cambridge, England) 2008;(28):3248-50.
2008: Cwikla Jaroslaw B; Mikolajczak Renata; Pawlak Dariusz; Buscombe John R; Nasierowska-Guttmejer Anna; Bator Andrzej; Maecke Helmut R; Walecki Jerzy
Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(7):1060-5.
2008: Cescato Renzo; Erchegyi Judith; Waser Beatrice; Piccand Véronique; Maecke Helmut R; Rivier Jean E; Reubi Jean Claude
Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting.
Journal of medicinal chemistry 2008;51(13):4030-7.
2008: Ginj Mihaela; Zhang Hanwen; Eisenwiener Klaus-Peter; Wild Damian; Schulz Stefan; Rink Hans; Cescato Renzo; Reubi Jean Claude; Maecke Helmut R
New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):2019-27.
2008: Fani Melpomeni; André João P; Maecke Helmut R
68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals.
Contrast media & molecular imaging 2008;3(2):67-77.
2008: Heppeler Axel; André João P; Buschmann Ingeborg; Wang Xuejuan; Reubi Jean-Claude; Hennig Michael; Kaden Thomas A; Maecke Helmut R
Metal-ion-dependent biological properties of a chelator-derived somatostatin analogue for tumour targeting.
Chemistry (Weinheim an der Bergstrasse, Germany) 2008;14(10):3026-34.
2007: Oyen W J G; Bodei L; Giammarile F; Maecke H R; Tennvall J; Luster M; Brans B
Targeted therapy in nuclear medicine--current status and future prospects.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(11):1782-92.
2007: Zhang Hanwen; Schuhmacher Jochen; Waser Beatrice; Wild Damian; Eisenhut Michael; Reubi Jean Claude; Maecke Helmut R
DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours.
European journal of nuclear medicine and molecular imaging 2007;34(8):1198-208.
2007: Antunes P; Ginj M; Zhang H; Waser B; Baum R P; Reubi J C; Maecke H
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
European journal of nuclear medicine and molecular imaging 2007;34(7):982-93.
2007: Gotthardt Martin; van Eerd-Vismale Julliëtte; Oyen Wim J G; de Jong Marion; Zhang Hanwen; Rolleman Edgar; Maecke Helmut R; Béhé Martin; Boerman Otto
Indication for different mechanisms of kidney uptake of radiolabeled peptides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(4):596-601.
2007: Antunes Patricia; Delgado Rita; Drew Michael G B; Félix Vitor; Maecke Helmut
Copper complexes of new benzodioxotetraaza macrocycles with potential applications in nuclear medicine.
Inorganic chemistry 2007;46(8):3144-53.
2007: Trejtnar Frantisek; Laznicek Milan; Laznickova Alice; Kopecky Martin; Petrik Milos; Béhé Martin; Schmidt Jörg; Maecke Helmut; Maina Theodosia; Nock Berthold
Biodistribution and elimination characteristics of two 111In-labeled CCK-2/gastrin receptor-specific peptides in rats.
Anticancer research 2007;27(2):907-12.
2007: Antunes Patricia; Ginj Mihaela; Walter Martin A; Chen Jianhua; Reubi Jean-Claude; Maecke Helmut R
Influence of different spacers on the biological profile of a DOTA-somatostatin analogue.
Bioconjugate chemistry 2007;18(1):84-92.
2007: Maecke H R; André J P
68Ga-PET radiopharmacy: A generator-based alternative to 18F-radiopharmacy.
Ernst Schering Research Foundation workshop 2007;(62):215-42.
2006: Ginj Mihaela; Schmitt Jörg S; Chen Jianhua; Waser Beatrice; Reubi Jean-Claude; de Jong Marion; Schulz Stefan; Maecke Helmut R
Design, synthesis, and biological evaluation of somatostatin-based radiopeptides.
Chemistry & biology 2006;13(10):1081-90.
2006: Hubalewska-Dydejczyk A; Fröss-Baron K; Mikolajczak R; Maecke H R; Huszno B; Pach D; Sowa-Staszczak A; Janota B; Szybinski P; Kulig J
99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience.
European journal of nuclear medicine and molecular imaging 2006;33(10):1123-33.
2006: Kneifel Stefan; Cordier Dominik; Good Stephan; Ionescu Mihai C S; Ghaffari Anthony; Hofer Silvia; Kretzschmar Martin; Tolnay Markus; Apostolidis Christos; Waser Beatrice; Arnold Marlene; Mueller-Brand Jan; Maecke Helmut R; Reubi Jean Claude; Merlo Adrian
Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance p.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(12):3843-50.
2006: Uusijärvi Helena; Bernhardt Peter; Rösch Frank; Maecke Helmut R; Forssell-Aronsson Eva
Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(5):807-14.
2006: Ni Ying; Wu Renyi; Xu Wen; Maecke Helmut; Flammer Josef; Haefliger Ivan O
Effect of cAMP on porcine ciliary transepithelial short-circuit current, sodium transport, and chloride transport.
Investigative ophthalmology & visual science 2006;47(5):2065-74.
2006: Forrer Flavio; Waldherr Christian; Maecke Helmut R; Mueller-Brand Jan
Targeted radionuclide therapy with 90Y-DOTATOC in patients with neuroendocrine tumors.
Anticancer research 2006;26(1B):703-7.
2006: Degen Lukas; Matzinger Daniel; Drewe Juergen; Nisslé Sonja; Maecke Helmut; Lengsfeld Hans; Hadvary Paul; Beglinger Christoph
Role of free fatty acids in regulating gastric emptying and gallbladder contraction.
Digestion 2006;74(3-4):131-9.
2005: Ginj Mihaela; Hinni Karin; Tschumi Sibylle; Schulz Stefan; Maecke Helmut R
Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(12):2097-103.
2005: Forrer Flavio; Uusijärvi Helena; Storch Daniel; Maecke Helmut R; Mueller-Brand Jan
Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(8):1310-6.
2005: Grünberg Jürgen; Novak-Hofer Ilse; Honer Michael; Zimmermann Kurt; Knogler Karin; Bläuenstein Peter; Ametamey Simon; Maecke Helmut R; Schubiger P August
In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5112-20.
2005: Maina Theodosia; Nock Berthold A; Zhang Hanwen; Nikolopoulou Anastasia; Waser Beatrice; Reubi Jean-Claude; Maecke Helmut R
Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(5):823-30.
2005: Forrer F; Mueller-Brand J; Maecke H
Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours.
European journal of nuclear medicine and molecular imaging 2005;32(4):511-2; author reply 513.
2005: Ginj Mihaela; Chen Jianhua; Walter Martin A; Eltschinger Veronique; Reubi Jean Claude; Maecke Helmut R
Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1136-45.
2005: Maecke Helmut R; Hofmann Michael; Haberkorn Uwe
(68)Ga-labeled peptides in tumor imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():172S-8S.
2005: Kwekkeboom Dik J; Mueller-Brand Jan; Paganelli Giovanni; Anthony Lowell B; Pauwels Stanislas; Kvols Larry K; O'dorisio Thomas M; Valkema Roelf; Bodei Lisa; Chinol Marco; Maecke Helmut R; Krenning Eric P
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():62S-6S.
2005: Maecke H R
Radiolabeled peptides in nuclear oncology: influence of peptide structure and labeling strategy on pharmacology.
Ernst Schering Research Foundation workshop 2005;(49):43-72.
2004: Plachcinska Anna; Mikolajczak Renata; Maecke Helmut; Kozak Józef; Michalski Andrzej; Rzeszutek Katarzyna; Kusmierek Jacek
Efficacy of 99mTc-EDDA/HYNIC-TOC scintigraphy in differential diagnosis of solitary pulmonary nodules.
Cancer biotherapy & radiopharmaceuticals 2004;19(5):613-20.
2004: Zhang Hanwen; Chen Jianhua; Waldherr Christian; Hinni Karin; Waser Beatrice; Reubi Jean Claude; Maecke Helmut R
Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors.
Cancer research 2004;64(18):6707-15.
2004: Schmitt Anneli; Bernhardt Peter; Nilsson Ola; Ahlman Håkan; Kölby Lars; Maecke Helmut R; Forssell-Aronsson Eva
Radiation therapy of small cell lung cancer with 177Lu-DOTA-Tyr3-octreotate in an animal model.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(9):1542-8.
2004: Pless Miklos; Waldherr Christian; Maecke Helmut; Buitrago Carlos; Herrmann Richard; Mueller-Brand Jan
Targeted radiotherapy for small cell lung cancer using 90Yttrium-DOTATOC, an Yttrium-labelled somatostatin analogue: a pilot trial.
Lung cancer (Amsterdam, Netherlands) 2004;45(3):365-71.
2004: Forrer F; Uusijärvi H; Waldherr C; Cremonesi M; Bernhardt P; Mueller-Brand J; Maecke H R
A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours.
European journal of nuclear medicine and molecular imaging 2004;31(9):1257-62.
2004: Plachcinska Anna; Mikolajczak Renata; Maecke Helmut R; Michalski Andrzej; Rzeszutek Katarzyna; Kozak Józef; Kusmierek Jacek
99mTc-EDDA/HYNIC-TOC scintigraphy in the differential diagnosis of solitary pulmonary nodules.
European journal of nuclear medicine and molecular imaging 2004;31(7):1005-10.
2004: Plachcinska Anna; Mikolajczak Renata; Maecke Helmut; Mlodkowska Ewa; Kunert-Radek Jolanta; Michalski Andrzej; Rzeszutek Katarzyna; Kozak Jozek; Kusmierek Jacek
Clinical usefulness of 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: a pilot study.
Cancer biotherapy & radiopharmaceuticals 2004;19(2):261-70.
2004: Ginj Mihaela; Maecke Helmut R
Radiometallo-labeled peptides in tumor diagnosis and therapy.
Metal ions in biological systems 2004;42():109-42.
2004: Meier G; Waldherr C; Herrmann R; Maecke H; Mueller-Brand J; Pless M
Successful targeted radiotherapy with 90Y-DOTATOC in a patient with Merkel cell carcinoma. A Case Report.
Oncology 2004;66(2):160-3.
2003: Plachcinska Anna; Mikolajczak Renata; Maecke Helmut R; Mlodkowska Ewa; Kunert-Radek Jolanta; Michalski Andrzej; Rzeszutek Katarzyna; Kozak Józef; Kusmierek Jacek
Clinical usefulness of 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: a preliminary communication.
European journal of nuclear medicine and molecular imaging 2003;30(10):1402-6.
2002: Waldherr Christian; Pless Miklos; Maecke Helmut R; Schumacher Tilmann; Crazzolara Armin; Nitzsche Egbert U; Haldemann Andreas; Mueller-Brand Jan
Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(5):610-6.
2002: Schumacher Tilmann; Waldherr Christian; Mueller-Brand Jan; Maecke Helmut
Kidney failure after treatment with 90Y-DOTATOC.
European journal of nuclear medicine and molecular imaging 2002;29(3):435.
2002: Ugur Omer; Kothari Paresh J; Finn Ronald D; Zanzonico Pat; Ruan Shutian; Guenther Ilonka; Maecke Helmut R; Larson Steven M
Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.
Nuclear medicine and biology 2002;29(2):147-57.
2001: Hofmann M; Maecke H; Börner R; Weckesser E; Schöffski P; Oei L; Schumacher J; Henze M; Heppeler A; Meyer J; Knapp H
Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data.
European journal of nuclear medicine 2001;28(12):1751-7.
2001: Hofer S; Eichhorn K; Freitag P; Reubi J C; Muller-Brand J; Maecke H; Merlo A
Successful diffusible brachytherapy (dBT) of a progressive low-grade astrocytoma using the locally injected peptidic vector and somatostatin analogue [90Y]-DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC).
Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001;131(43-44):640-4.
2001: Degen L; Matzinger D; Merz M; Appel-Dingemanse S; Osborne S; Lüchinger S; Bertold R; Maecke H; Beglinger C
Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects.
Alimentary pharmacology & therapeutics 2001;15(11):1745-51.
2001: Waldherr C; Pless M; Maecke H R; Haldemann A; Mueller-Brand J
The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(7):941-5.
2001: Waldherr C; Schumacher T; Pless M; Crazzolara A; Maecke H R; Nitzsche E U; Haldemann A; Mueller-Brand J
Radiopeptide transmitted internal irradiation of non-iodophil thyroid cancer and conventionally untreatable medullary thyroid cancer using.
Nuclear medicine communications 2001;22(6):673-8.
2001: Moll S; Nickeleit V; Mueller-Brand J; Brunner F P; Maecke H R; Mihatsch M J
A new cause of renal thrombotic microangiopathy: yttrium 90-DOTATOC internal radiotherapy.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;37(4):847-51.
2000: Bangard M; Béhé M; Guhlke S; Otte R; Bender H; Maecke H R; Biersack H J
Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.
European journal of nuclear medicine 2000;27(6):628-37.
2000: Waldherr C; Haldemann A; Maecke H R; Crazzolara A; Mueller-Brand J
Exceptional results in neuroendocrine-metastases-caused paraplegia treated with [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC), a radiolabelled somatostatin analogue.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2000;12(2):121-3.
1999: Otte A; Herrmann R; Heppeler A; Behe M; Jermann E; Powell P; Maecke H R; Muller J
Yttrium-90 DOTATOC: first clinical results.
European journal of nuclear medicine 1999;26(11):1439-47.
1999: Cremonesi M; Ferrari M; Zoboli S; Chinol M; Stabin M G; Orsi F; Maecke H R; Jermann E; Robertson C; Fiorenza M; Tosi G; Paganelli G
Biokinetics and dosimetry in patients administered with (111)In-DOTA-Tyr(3)-octreotide: implications for internal radiotherapy with (90)Y-DOTATOC.
European journal of nuclear medicine 1999;26(8):877-86.
1999: André J P; Maecke H R; Tóth E; Merbach A A
Synthesis and physicochemical characterization of a novel precursor for covalently bound macromolecular MRI contrast agents.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 1999;4(3):341-7.
1998: Otte A; Mueller-Brand J; Dellas S; Nitzsche E U; Herrmann R; Maecke H R
Yttrium-90-labelled somatostatin-analogue for cancer treatment.
Lancet 1998;351(9100):417-8.
1997: Otte A; Jermann E; Behe M; Goetze M; Bucher H C; Roser H W; Heppeler A; Mueller-Brand J; Maecke H R
DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy.
European journal of nuclear medicine 1997;24(7):792-5.
1997: Merlo A; Jermann E; Hausmann O; Chiquet-Ehrismann R; Probst A; Landolt H; Maecke H R; Mueller-Brand J; Gratzl O
Biodistribution of 111In-labelled SCN-bz-DTPA-BC-2 MAb following loco-regional injection into glioblastomas.
International journal of cancer. Journal international du cancer 1997;71(5):810-6.
1997: Novak-Hofer I; Zimmermann K; Maecke H R; Amstutz H P; Carrel F; Schubiger P A
Tumor uptake and metabolism of copper-67-labeled monoclonal antibody chCE7 in nude mice bearing neuroblastoma xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(4):536-44.
1996: Stoeckli T C; Zimmerli W; Maecke H R; Fridrich R
Comparison of chemotaxis and superoxide generation of indium-111-oxine- and technetium-99m-HMPAO-labelled granulocytes.
Scandinavian journal of clinical and laboratory investigation 1996;56(4):305-9.
1996: Magnani P; Paganelli G; Modorati G; Zito F; Songini C; Sudati F; Koch P; Maecke H R; Brancato R; Siccardi A G; Fazio F
Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(6):967-71.
1994: Schwizer W; Fraser R; Maecke H; Siebold K; Funck R; Fried M
Gd-DOTA as a gastrointestinal contrast agent for gastric emptying measurements with MRI.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1994;31(4):388-93.
1993: Smith A; Alberto R; Blaeuenstein P; Novak-Hofer I; Maecke H R; Schubiger P A
Preclinical evaluation of 67Cu-labeled intact and fragmented anti-colon carcinoma monoclonal antibody MAb35.
Cancer research 1993;53(23):5727-33.
1992: Schwizer W; Maecke H; Fried M
Measurement of gastric emptying by magnetic resonance imaging in humans.
Gastroenterology 1992;103(2):369-76.
1991: Smith-Jones P M; Fridrich R; Kaden T A; Novak-Hofer I; Siebold K; Tschudin D; Maecke H R
Antibody labeling with copper-67 using the bifunctional macrocycle 4-[(1,4,8,11-tetraazacyclotetradec-1-yl)methyl]benzoic acid.
Bioconjugate chemistry 1991;2(6):415-21.
1990: Ruser G; Ritter W; Maecke H R
Synthesis and evaluation of two new bifunctional carboxymethylated tetraazamacrocyclic chelating agents for protein labeling with indium-111.
Bioconjugate chemistry 1990;1(5):345-9.
1989: Maecke H R; Riesen A; Ritter W
The molecular structure of indium-DTPA.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(7):1235-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Helmut Maecke

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Disorders

Living Beings

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Helmut Maecke (preview)

All Publications